New combo drug doses aim to wipe out whipworm in toddlers
NCT ID NCT06184399
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether higher doses of ivermectin, combined with albendazole, are safe and effective for treating whipworm infections in children aged 2 to 5 years. The trial involved 260 children in Tanzania and compared different doses of ivermectin, including a new dissolvable tablet. The main goal was to see how many children were cured of the infection after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ivermectin and albendazole
- What this could lead to
- If successful, this could point toward a more effective treatment for whipworm infections in young children, reducing the burden of this parasitic disease.
- What could go wrong
- This is a Phase 2 dose-ranging trial with 260 children, so results are preliminary. The treatment may not prove more effective than current options, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASCARIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Public Health Laboratory Ivo de Carneri
Chake Chake, Tanzania
More trials for these conditions
Other studies related to the condition(s) this trial covers.